Cargando…
Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
Pyrazinamide (PZA) is a frontline antituberculosis (anti-TB) drug used in both first- and second-line treatment regimens. However, due to complex laboratory requirements, the PZA susceptibility test is rarely performed, leading to a scarcity of data on susceptibility to PZA. Bangladesh is a country...
Autores principales: | Rahman, Arfatur, Ferdous, Sara Sabrina, Ahmed, Shahriar, Rahman, S. M. Mazidur, Uddin, Mohammad Khaja Mafij, Pholwat, Suporn, Gratz, Jean, Houpt, Eric, Banu, Sayera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571327/ https://www.ncbi.nlm.nih.gov/pubmed/28630193 http://dx.doi.org/10.1128/AAC.00511-17 |
Ejemplares similares
-
Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2020) -
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001) -
Molecular Epidemiology and Genetic Diversity of Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2022) -
Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
por: Shi, Dawei, et al.
Publicado: (2022) -
Performance of TaqMan array card to detect TB drug resistance on direct specimens
por: Banu, Sayera, et al.
Publicado: (2017)